MENU
TGTX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
TG Therapeutics (TGTX) Earnings Date & Reports
TG Therapeutics Inc is a fully integrated, commercial-stage biotechnology company focused on acquiring, developing, and commercializing novel treatments for B-cell diseases... Show more
Industry: #Biotechnology
A.I. Advisor
published Earnings
TGTX is expected to report earnings to rise 640.00% to 37 cents per share on November 02
Q3'26
Est.
$0.37
Q2'26
Missed
by $0.26
Q1'26
Missed
by $0.16
Q4'25
Missed
by $0.23
Q3'25
Beat
by $2.21
The last earnings report on August 03 showed earnings per share of 5 cents, missing the estimate of 31 cents. With 330.24K shares outstanding, the current market capitalization sits at 8.39B.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Interesting Articles
A.I. Advisor
published General Information
General Information
a biopharmaceutical company
Industry Biotechnology
Industry
Biotechnology
Address
3020 Carrington Mill Boulevard
Phone
+1 212 554-4484
Employees
399
Web
https://www.tgtherapeutics.com